Prime Medicine (PRME) Amortizatization of Intangibles (2021 - 2026)

Prime Medicine has reported Amortizatization of Intangibles for 6 years, with the latest figure at $2.8 million in Q1 2026.

• For the quarter ending Q1 2026, Amortizatization of Intangibles rose 17.82% year-over-year to $2.8 million; the trailing twelve-month figure through Mar 2026 stood at $10.1 million (down 11.31% YoY), and the FY2025 full-year result was $9.7 million, down 21.51% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $2.8 million, up from $2.6 million in the prior quarter.
• The five-year high for Amortizatization of Intangibles was $9.9 million in Q4 2022, with the low at -$2.0 million in Q2 2022.
• Historically, Amortizatization of Intangibles has averaged $2.8 million across 5 years, with a median of $2.4 million in 2025.
• The largest YoY upside for Amortizatization of Intangibles was 2004.7% in 2023 against a maximum downside of 66.15% in 2023.
• Prime Medicine's Amortizatization of Intangibles stood at $9.9 million in 2022, then slumped by 66.15% to $3.3 million in 2023, then plunged by 34.05% to $2.2 million in 2024, then gained by 17.89% to $2.6 million in 2025, then rose by 9.22% to $2.8 million in 2026.
• The last three Amortizatization of Intangibles figures came in at $2.8 million (Q1 2026), $2.6 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.